PEGINTERFERON BETA-1A for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 817 adverse event reports in the FDA FAERS database where PEGINTERFERON BETA-1A was used for Product used for unknown indication.
Most Reported Side Effects for PEGINTERFERON BETA-1A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Influenza like illness | 1,431 | 11.5% | 2 | 174 |
| Injection site erythema | 1,041 | 8.4% | 0 | 119 |
| Multiple sclerosis relapse | 945 | 7.6% | 2 | 578 |
| Fatigue | 673 | 5.4% | 2 | 142 |
| Headache | 587 | 4.7% | 0 | 105 |
| Pain | 580 | 4.7% | 2 | 111 |
| Injection site reaction | 569 | 4.6% | 1 | 51 |
| Device malfunction | 567 | 4.6% | 0 | 9 |
| Multiple sclerosis | 536 | 4.3% | 14 | 153 |
| Pyrexia | 503 | 4.0% | 4 | 135 |
| Memory impairment | 455 | 3.7% | 1 | 45 |
| Malaise | 448 | 3.6% | 3 | 101 |
| Injection site pain | 435 | 3.5% | 0 | 35 |
| Fall | 406 | 3.3% | 5 | 214 |
| Drug dose omission | 389 | 3.1% | 0 | 12 |
Other Indications for PEGINTERFERON BETA-1A
Multiple sclerosis (11,105)
Relapsing-remitting multiple sclerosis (390)
Maternal exposure timing unspecified (82)
Secondary progressive multiple sclerosis (11)
Demyelination (7)
Relapsing multiple sclerosis (6)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)